GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against invasive meningococcal disease, IMD, caused by bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback